Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,834,197
+$1,881,954 QoQ
Shares Held
9,415
+227.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#288
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Havemeyer Place LP holds $27,177,295 across 19 Biotechnology names. ALNY ranks #1 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
9,415 | $2,834,197 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
71,019 | $2,513,362 | |
| 3 | QURE |
uniQure N.V.
|
50,812 | $2,340,400 | |
| 4 | INSM |
INSMED Inc
|
19,121 | $2,038,681 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
33,490 | $1,916,297 | |
| 6 | BNTX |
BioNTech SE
|
20,283 | $1,887,333 | |
| 7 | ARGX |
Argenx SE
|
1,948 | $1,807,295 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,248 | $1,529,322 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,834,197 | 9,415 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $952,243 | 2,878 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $118,499 | 298 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||